264 related articles for article (PubMed ID: 12082019)
21. Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea.
Thompson HJ; McGinley JN; Rothhammer K; Singh M
Carcinogenesis; 1995 Oct; 16(10):2407-11. PubMed ID: 7586143
[TBL] [Abstract][Full Text] [Related]
22. Chemical carcinogen-induced rat mammary carcinogenesis is a potential model of p21-activated kinase positive female breast cancer.
Duderstadt EL; McQuaide SA; Sanders MA; Samuelson DJ
Physiol Genomics; 2021 Feb; 53(2):61-68. PubMed ID: 33346690
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of mammary gland tumors by short-term treatment of estradiol-3-benzoate associated with down-regulation of estrogen receptor ERalpha and ERbeta.
Kang JS; Kim S; Che JH; Nam KT; Kim DJ; Jang DD; Yang KH
Oncol Rep; 2004 Oct; 12(4):689-93. PubMed ID: 15375486
[TBL] [Abstract][Full Text] [Related]
24. Effects of 5,6-benzoflavone, indole-3-carbinol (I3C) and diindolylmethane (DIM) on chemically-induced mammary carcinogenesis: is DIM a substitute for I3C?
Lubet RA; Heckman BM; De Flora SL; Steele VE; Crowell JA; Juliana MM; Grubbs CJ
Oncol Rep; 2011 Sep; 26(3):731-6. PubMed ID: 21617870
[TBL] [Abstract][Full Text] [Related]
25. An expression study of hormone receptors in spontaneously developed, carcinogen-induced and hormone-induced mammary tumors in female Noble rats.
Cheung SY; Yuen MT; Choi HL; Cheng HK; Huang Y; Chen S; Chan FL
Int J Oncol; 2003 Jun; 22(6):1383-95. PubMed ID: 12739009
[TBL] [Abstract][Full Text] [Related]
26. Determination of the number of events required for mammary carcinogenesis in the Sprague-Dawley female rat.
Isaacs JT
Cancer Res; 1985 Oct; 45(10):4827-32. PubMed ID: 3928142
[TBL] [Abstract][Full Text] [Related]
27. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy.
McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC
Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843
[TBL] [Abstract][Full Text] [Related]
28. Atlas and histologic classification of tumors of the rat mammary gland.
Russo J; Russo IH
J Mammary Gland Biol Neoplasia; 2000 Apr; 5(2):187-200. PubMed ID: 11149572
[TBL] [Abstract][Full Text] [Related]
29. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
[TBL] [Abstract][Full Text] [Related]
30. Gene expression changes associated with chemically induced rat mammary carcinogenesis.
Lu J; Pei H; Kaeck M; Thompson HJ
Mol Carcinog; 1997 Oct; 20(2):204-15. PubMed ID: 9364210
[TBL] [Abstract][Full Text] [Related]
31. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
Swanson SM; Christov K
Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
[TBL] [Abstract][Full Text] [Related]
32. Dose response chemopreventive potential of allyl isothiocyanate against 7,12-dimethylbenz(a)anthracene induced mammary carcinogenesis in female Sprague-Dawley rats.
Rajakumar T; Pugalendhi P; Thilagavathi S
Chem Biol Interact; 2015 Apr; 231():35-43. PubMed ID: 25744308
[TBL] [Abstract][Full Text] [Related]
33. N-Nitroso-N-methylurea elicits mammary cancer in resistant and sensitive rat strains.
Huggins CB; Ueda N; Wiessler M
Proc Natl Acad Sci U S A; 1981 Feb; 78(2):1185-8. PubMed ID: 6785750
[TBL] [Abstract][Full Text] [Related]
34. Repeated administration of carcinogen in critical developmental periods increases susceptibility of female Wistar: han rats to mammary carcinogenesis induction.
Bojková B; Ahlers I; Kubatka P; Mociková K; Mníchová M; Ahlersová E
Neoplasma; 2000; 47(4):230-3. PubMed ID: 11043827
[TBL] [Abstract][Full Text] [Related]
35. A mammary cancer suppressor gene and its site of action in the rat.
Isaacs JT
Cancer Res; 1991 Mar; 51(6):1591-5. PubMed ID: 1900214
[TBL] [Abstract][Full Text] [Related]
36. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
Kuang SQ; Liao L; Wang S; Medina D; O'Malley BW; Xu J
Cancer Res; 2005 Sep; 65(17):7993-8002. PubMed ID: 16140972
[TBL] [Abstract][Full Text] [Related]
37. Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
Rose DP; Noonan JJ
Cancer Res; 1982 Jan; 42(1):35-8. PubMed ID: 6797725
[TBL] [Abstract][Full Text] [Related]
38. Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer.
Li JJ; Papa D; Davis MF; Weroha SJ; Aldaz CM; El-Bayoumy K; Ballenger J; Tawfik O; Li SA
Mol Carcinog; 2002 Jan; 33(1):56-65. PubMed ID: 11807958
[TBL] [Abstract][Full Text] [Related]
39. Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat.
Ip C; Singh M; Thompson HJ; Scimeca JA
Cancer Res; 1994 Mar; 54(5):1212-5. PubMed ID: 8118808
[TBL] [Abstract][Full Text] [Related]
40. Suppression of mammary-derived growth inhibitor gene expression by growth hormone and insulin-like growth factor I.
Huynh H; Beamer W
Int J Oncol; 1998 Sep; 13(3):577-82. PubMed ID: 9683796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
